×
Orlistat in Clozapine- or Olanzapine-Treated Patients With Overweight or Obesity: A 16-Week Randomized, Double-Blind, Placebo-Controlled Trial PDF
$ 40.00
Orlistat in Clozapine- or Olanzapine-Treated Patients With Overweight or Obesity: A 16-Week Randomized, Double-Blind, Placebo-Controlled Trial PDF quantity
$ 40.00
×
Depressive Disorders Are Related to Nicotine Dependence in the Population But Do Not Necessarily Hamper Smoking Cessation. PDF
$ 40.00
Depressive Disorders Are Related to Nicotine Dependence in the Population But Do Not Necessarily Hamper Smoking Cessation. PDF quantity
$ 40.00
×
Empirical Examination of a Proposed Refinement to DSM-IV Posttraumatic Stress Disorder Symptom Criteria Using the National Comorbidity Survey Replication Data PDF
$ 40.00
Empirical Examination of a Proposed Refinement to DSM-IV Posttraumatic Stress Disorder Symptom Criteria Using the National Comorbidity Survey Replication Data PDF quantity
$ 40.00
×
A Randomized, Double-Blind, Placebo-Controlled Add-On Trial of Quetiapine in Outpatients With Bipolar Disorder and Alcohol Use Disorders PDF
$ 40.00
A Randomized, Double-Blind, Placebo-Controlled Add-On Trial of Quetiapine in Outpatients With Bipolar Disorder and Alcohol Use Disorders PDF quantity
$ 40.00
×
A Pharmacokinetic and Clinical Evaluation of Switching Patients With Bipolar I Disorder From Delayed-Release to Extended-Release Divalproex PDF
$ 40.00
A Pharmacokinetic and Clinical Evaluation of Switching Patients With Bipolar I Disorder From Delayed-Release to Extended-Release Divalproex PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart